The National Agency for Food and Drugs Administration and Control (NAFDAC) in Nigeria has announced a voluntary recall of all lots of the male enhancement dietary supplement MR.7 SUPER 700000 capsules. The recall is primarily due to serious safety concerns following an analysis conducted by the US Food and Drug Administration (FDA), which discovered that the product contains undeclared active ingredients, namely sildenafil and tadalafil. These substances are phosphodiesterase (PDE-5) inhibitors, which are commonly used in FDA-approved medications for treating male erectile dysfunction but are not sanctioned for use in dietary supplements.

NAFDAC highlighted that the presence of sildenafil and tadalafil in the MR.7 SUPER 700000 capsules classifies them as unapproved drugs. Since these ingredients have not undergone safety and efficacy evaluations within the context of dietary supplements, the agency warned that they could pose significant health risks to consumers. The presence of such potent active ingredients in a product marketed as a dietary supplement raises serious regulatory and public health concerns, particularly regarding consumer safety and informed consent.

The agency urged consumers to avoid the use of MR.7 SUPER 700000 capsules and to report any adverse reactions associated with the product. This move represents NAFDAC’s commitment to ensuring public safety and compliance with regulatory standards in the dietary supplement market. The recall serves as a reminder for consumers to be vigilant about the products they use, particularly those advertised for male enhancement.